Viatris Balance Sheet
NASDAQ: VTRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Viatris financial position
At the end of fiscal 2025, Viatris reported total assets of $37.19 billion, down 10.4% from a year earlier against total liabilities of $22.48 billion. Shareholders' equity stood at $14.71 billion, or 39.6% of assets. The company held $1.32 billion in cash and equivalents against $14.41 billion of debt, a net debt position of $13.09 billion.
The current ratio (current assets divided by current liabilities) was 1.38, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.98.
Summary generated from market data by MetaCap's automated system. Methodology
Viatris balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.32B | 734.80M | 991.90M | 1.26B | 701.20M | 844.40M | 475.60M | 388.10M |
| Short-Term Investments | 40.70M | 38.00M | 37.00M | 35.30M | 38.20M | 39.10M | 26.80M | — |
| Receivables | 3.03B | 3.22B | 3.70B | 3.81B | 4.27B | 4.84B | 3.06B | — |
| Inventory | 4.00B | 3.85B | 3.47B | 3.52B | 3.98B | 5.47B | 2.67B | — |
| Total Current Assets | 9.79B | 9.52B | 12.98B | 10.64B | 10.90B | 12.87B | 6.76B | — |
| Property, Plant & Equipment | 2.61B | 2.67B | 2.76B | 3.02B | 3.19B | 3.46B | 2.15B | — |
| Goodwill | 6.75B | 9.13B | 9.87B | 10.43B | 12.11B | 12.35B | 9.59B | 9.75B |
| Intangible Assets | 15.10B | 17.07B | 19.18B | 22.61B | 26.13B | 29.68B | 11.65B | — |
| Total Assets | 37.19B | 41.50B | 47.69B | 50.02B | 54.84B | 61.55B | 31.26B | — |
| Accounts Payable | 1.75B | 1.85B | 1.94B | 1.77B | 1.66B | 1.90B | 1.53B | — |
| Short-Term Debt | 1.93B | 600.00K | 1.93B | 1.25B | 1.86B | 2.26B | 1.46B | — |
| Total Current Liabilities | 7.09B | 5.78B | 7.78B | 6.75B | 9.88B | 10.56B | 5.57B | — |
| Long-Term Debt | 12.48B | 14.04B | 16.19B | 18.02B | 19.72B | 22.43B | 11.21B | — |
| Total Liabilities | 22.48B | 22.87B | 27.22B | 28.95B | 34.35B | 38.60B | 19.37B | — |
| Shareholders' Equity | 14.71B | 18.64B | 20.47B | 21.07B | 20.49B | 22.95B | 0 | 12.17B |
| Retained Earnings | -388.30M | 3.42B | 4.64B | 5.18B | 3.69B | 5.36B | 6.03B | — |
| Total Debt | 14.41B | 14.04B | 18.12B | 19.27B | 21.58B | 24.69B | 12.67B | — |
| Net Cash (Debt) | -13.05B | -13.27B | -17.09B | -17.97B | -20.84B | -23.80B | -12.17B | 388.10M |
| Shares Outstanding | — | — | — | — | — | — | 100 | — |
This table shows 8 annual periods of Viatris's balance sheet, from FY 2025 back to FY 2018, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow VTRS's reporting calendar. What is a balance sheet?